Delivery Order SPE2DB20D1109-SPE2DB24FP48J

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a large Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, covers a broad range of pharmaceutical and medical supply products to support military healthcare programs globally. The specific delivery order being referenced is for the supply of 90 mg/mL Stelara syringes, a specialty medication, with a ceiling...
This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999.00 through December 31, 2025, enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $11,743.23 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded by the DLA to Amerisourcebergen, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp (the prime contractor) and the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, allows DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to support military treatment programs and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for $999,999,999 that runs through November 2026. The delivery order is for STELARA 90 MG/ML syringes, a specialty medication, with a ceiling value of $16,656.55 and a completion date of November 21, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract delivers STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a ceiling value of $307,182.05 and a completion date of February 21, 2024. This delivery order is part of the DLA's broader efforts to provide essential pharmaceutical and medical supplies to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This specific delivery order, valued at $13,966.41, is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a ceiling value of $51,614.77 and a performance period through December 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $114,787.52, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a completion date of July 11, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP48J
    Delivery Order

This is a delivery order award under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, who was awarded a $999,999,999 IDC with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific $7,300.01 delivery order is for STELARA 90 MG/ML syringes. The contract has a firm fixed price and an ultimate completion date of July 11, 2024. There was no set-aside designation indicated for this award.

Generated 2/27/25, 11:10 AM